Intracranial Pressure Monitoring for Pediatric Traumatic Brain Injury
(BELA TRIPP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the best treatment for severe traumatic brain injury (TBI) in children by comparing two methods. One group receives treatment guided by intracranial pressure (ICP) monitoring, which checks the pressure inside the skull. The other group follows a protocol based on imaging and physical exams without invasive monitoring. The goal is to determine if one approach aids recovery better than the other. Suitable candidates for this trial are children aged 1-12 who have suffered a severe non-penetrating head injury and are admitted to the hospital within 24 hours of the injury. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve future treatment strategies for children with severe TBI.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that intracranial pressure monitoring is safe for pediatric traumatic brain injury?
Research has shown that monitoring pressure inside the skull can be safely conducted in children with severe head injuries. One study performed this procedure without causing additional harm, but it did not lower the risk of death or the need for further brain surgeries. Another study found that while this monitoring might increase survival rates, it did not improve long-term recovery. For example, some children scored lower on a test measuring everyday skills six months after treatment. Although generally well-tolerated, this monitoring has not clearly demonstrated benefits in reducing serious complications from head injuries.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores two different approaches to managing severe traumatic brain injury in children. One approach uses invasive intracranial pressure (ICP) monitoring, which is guided by the Brain Trauma Foundation Guidelines, to provide precise measurements of pressure inside the skull. This can help tailor treatment to prevent further brain injury. The other approach, known as the CREVICE protocol, avoids invasive monitoring and relies on imaging and clinical examination for decision-making. By comparing these two methods, researchers hope to determine the most effective way to manage pediatric traumatic brain injuries, potentially improving outcomes and reducing risks associated with invasive procedures.
What evidence suggests that intracranial pressure monitoring is effective for pediatric traumatic brain injury?
This trial will compare two approaches for managing pediatric severe traumatic brain injury. One arm will use a protocol based on invasive intracranial pressure (ICP) monitoring, while the other will follow the CREVICE protocol, which does not involve ICP monitoring. Research has shown mixed results regarding the effectiveness of monitoring pressure inside the skull in treating children with serious brain injuries. Some studies suggest that while this monitoring can increase survival rates, it might not lead to better long-term recovery. For example, one study found that monitoring improved survival rates but didn't necessarily enhance long-term recovery. Another review noted that monitoring might not reduce in-hospital deaths, possibly due to the severity of the injuries. Overall, the evidence on the impact of this monitoring remains unclear, with results varying based on different factors.12678
Who Is on the Research Team?
Randall Chesnut, MD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for children aged 1-12 who have suffered a non-penetrating traumatic brain injury (TBI) and are admitted to the hospital within 24 hours of the incident. They must have a severe TBI, indicated by a low score on the Glasgow Coma Scale (GCS), and consent from parents or guardians. Children with injuries suspected to be caused intentionally or those with certain unresponsive pupil conditions cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive treatment for severe traumatic brain injury guided by either ICP monitoring or imaging and clinical examination protocols
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of quality of life and functional outcomes
What Are the Treatments Tested in This Trial?
Interventions
- CREVICE
- ICP
ICP is already approved in European Union, United States, Canada for the following indications:
- Severe Traumatic Brain Injury (TBI) in children
- Severe Traumatic Brain Injury (TBI) in children
- Severe Traumatic Brain Injury (TBI) in children
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator